Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.494NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.167NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-5048.56China
B.1.267NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-5048.56China
B.1.165NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-2770.32China
B.1.554NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.243.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.2.5.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.450NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.130NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.444NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-4360.53China
AW.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.268NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.344NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.103NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.485NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.119NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.276NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.515NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.287NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.431NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.170NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.23NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.506NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.6.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.438.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.27NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
D.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.447NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.110.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.180NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.155NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.92NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.145NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.120NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.77NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AE.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.504NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AE.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.201NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.221NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.410NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.411NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.109NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.361NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.38NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.417NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.46NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-4360.53China
B.1.1.139NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used